Dopaminergic-peptidergic interactions in extrapyramidal disorders: a review of the clinical evidence
Gerstenbrand, F.; Poewe, W.
Advances in Neurology 45: 67-73
1987
ISSN/ISBN: 0091-3952 PMID: 2881452 Document Number: 293610
Document emailed within 1 workday
Related Documents
Gabay, S. 1981: Serotonergic-dopaminergic interactions: implications for hyperkinetic disorders Advances in Experimental Medicine and Biology 133: 585-601Andersson, J.C.; Morel, P.; Poilpre, E.; Baron, J.B. 1977: Statokinesimetric and clinical study of extrapyramidal disorders induced by neuroleptics in a population of mental patients Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 18(Special Issue): 35-43
Bartholini, G.; Scatton, B.; Worms, P.; Zivkovic, B.; Lloyd, K.G. 1981: Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems Advances in Biochemical Psychopharmacology 30: 119-128
El Ayadi, A.; Errami, M. 1999: Interactions between neomycin and cerebral dopaminergic and serotoninergic transmission in rats Therapie 54(5): 595-599
György, L. 1979: Role of dopaminergic and GABA-ergic interactions in seizure susceptibility Archives Internationales de Pharmacodynamie et de Therapie 241(2): 280-286
Barbeau, A. 1971: The nosology of extrapyramidal disorders Birth Defects Original Article Series 7(1): 156-166
Iorio, L.C.; Barnett, A.; Leitz, F.H.; Houser, V.P.; Korduba, C.A. 1983: SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems Journal of Pharmacology and Experimental Therapeutics 226(2): 462-468
Jones, R.; Rickards, H.; Cavanna, A.E. 2010: The prevalence of psychiatric disorders in epilepsy: a critical review of the evidence Functional Neurology 25(4): 191-194
Bylund, D.B. 1981: Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors Journal of Pharmacology and Experimental Therapeutics 217(1): 81-86
Il'iash, T.I.; Laskarzhevskaia, N.M. 1991: Extrapyramidal disorders occurring after taking cerucal Vrachebnoe Delo 10: 117-118
Terleckyj, I.; Sonsalla, P.K. 1994: The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors Journal of Pharmacology and Experimental Therapeutics 269(1): 44-50
Masmoudi, K.; Decocq, G.; Chetaille, E.; Rosa, A.; Mizon, J.P.; Andréjak, M. 1995: Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases Therapie 50(5): 451-454
Borcherding, S.M.; Stevens, R.; Nicholas, R.A.; Corley, C.R.; Self, T. 1996: Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions Journal of Family Practice 42(1): 69-78
Barkhatova, V.P.; Lebedeva, N.V.; Dashdorzhiĭn, O.; Demina, E.G.; Larskiĭ, E.G. 1990: Catecholamine metabolism in extrapyramidal disorders in patients with chronic hypertensive encephalopathy Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(7): 32-36
Lacković, Z.; Relja, M. 1983: Evidence for a widely distributed peripheral dopaminergic system Federation Proceedings 42(13): 3000-3004
Casas, M.; Franco, M.D.; Goikolea, J.M.; Jiménez-Arriero, M.A.; Martínez-Raga, J.; Roncero, C.; Szerman, N. 2008: Bipolar disorder associated to substance use disorders (dual diagnosis). Systematic review of the scientific evidence and expert consensus Actas Espanolas de Psiquiatria 36(6): 350-361
Coleman, J.H.; Hayes, P.E. 1975: Drug induced extrapyramidal effects--a review Diseases of the Nervous System 36(10): 591-593
Beliakov, N.P. 1973: Paroxysmal bioelectrical brain activity in patients with extrapyramidal disorders of the nervous system Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(9): 1330-1333
Jenner, P. 2004: Avoidance of dyskinesia: preclinical evidence for continuous dopaminergic stimulation Neurology 62(1 Suppl 1): S47-S55
Pania, L.; Gessab, G.L. 2002: Dopaminergic deficit and mood disorders International Clinical Psychopharmacology 17(Suppl 4): S1